PTPmu Solutions

PTPmu Solutions is a biotechnology company focused on developing novel therapeutics and diagnostics for invasive cancers, specifically targeting the PTPmu (PTPRM) protein. The company's technology is based on the discovery that a specific proteolytically cleaved form of PTPmu serves as a unique biomarker for migrating and invading cancer cells. Their lead programs include peptide-based agents designed to specifically target and label invasive tumor cells, facilitating both surgical resection and targeted drug delivery. By focusing on the invasive edge of tumors like glioblastoma, PTPmu Solutions aims to address the primary cause of cancer recurrence and treatment failure.